Pyramid Biosciences to Present at the 2022 Jefferies London Healthcare Conference

Pyramid Biosciences to Present at the 2022 Jefferies London Healthcare Conference

Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, announced today that Chief Executive Officer, Brian Lestini, M.D., Ph.D., will present at the 2022 Jefferies London Healthcare Conference on Thursday, November 17, 2022 at 2:40 PM GMT. Read more >>

Share this post